Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Myeloproliferative Disorders × thymoglobulin × 30 days × Clear all

Sponsor

Conditions

beta-Thalassemia 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Leukemia, Myelomonocytic, Juvenile 2 Leukemia, Myeloid, Acute 2 Thalassemia 1 Neurofibromatosis 1 1 Neoplasm, Residual 1 Myelodysplastic Syndromes 1 Lymphoma, Non-Hodgkin 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Leukemia, Large Granular Lymphocytic 1 Leukemia 1 Influenza, Human 1 Hodgkin Disease 1 Hematologic Neoplasms 1 Chromosome Aberrations 1 Chromosome 7, monosomy 1 Anemia, Sickle Cell 1 Anemia, Refractory, with Excess of Blasts 1

Interventions

ruxolitinib 6 fludarabine 6 Specimen Handling 6 fludarabine phosphate 4 Whole-Body Irradiation 4 Cyclophosphamide 4 Biopsy 4 Azacitidine 4 venetoclax 3 decitabine and cedazuridine drug combination 3 Mycophenolic Acid 3 Melphalan 3 Cytarabine 3 Busulfan 3 Tacrolimus 2 Stem Cell Transplantation 2 Sirolimus 2 Liposomes 2 Injections 2 Granulocyte Colony-Stimulating Factor 2 Daunorubicin 2 CPX-351 2 selinexor 1 quizartinib 1 plerixafor 1 pegylated granulocyte colony-stimulating factor 1 olutasidenib 1 luspatercept 1 letermovir 1 iadademstat 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡